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1. INTRODUCTION {#mbo3525-sec-0001}
===============

Bacterial lipoproteins (Lpp) belong to the class of lipid‐anchored proteins that in gram‐negative bacteria are attached in both the cytoplasmic and outer membranes, whereas in gram‐positive bacteria they are attached only in the cytoplasmic membrane (Hantke & Braun, [1973](#mbo3525-bib-0015){ref-type="ref"}; Nguyen & Götz, [2016](#mbo3525-bib-0042){ref-type="ref"}). Most Lpp are translocated across the cytoplasmic membrane by the bacterial SecYEG apparatus (Sugai & Wu, [1992](#mbo3525-bib-0063){ref-type="ref"}), but few by the twin‐arginine translocation (Tat) pathway (Lee, Tullman‐Ercek, & Georgiou, [2006](#mbo3525-bib-0032){ref-type="ref"}). The lipoprotein signal peptides possess at their C‐terminal end a conserved lipobox \[--Leu/Val/Ile‐3--Ser/Ala‐2--Ala/Gly‐1--Cys+1\], which is recognized by the modification machinery (Hayashi & Wu, [1990](#mbo3525-bib-0019){ref-type="ref"}). This machinery comprises three enzymes: the diacylglyceryl transferase (Lgt), the signal peptidase II (Lps) and finally N‐acyltransferase (Lnt) (Hayashi & Wu, [1990](#mbo3525-bib-0019){ref-type="ref"}; Inouye, Wang, Sekizawa, Halegoua, & Inouye, [1977](#mbo3525-bib-0024){ref-type="ref"}). Lgt transfers the sn‐1,2‐diacylglyceryl group from phosphatidylglycerol to the prolipoprotein (Sankaran & Wu, [1994](#mbo3525-bib-0052){ref-type="ref"}), Lsp recognizes the diacylglyceryl modification and cleaves between the amino acid at position --1 and the lipid‐modified cysteine (+1) residue (Hussain, Ichihara, & Mizushima, [1982](#mbo3525-bib-0023){ref-type="ref"}), and Lnt carries out the *N*‐acylation of the free N‐terminus of cysteine to form *N*‐acyl diacylglyceryl cysteine (Gan et al., [1995](#mbo3525-bib-0013){ref-type="ref"}). After the modification, the Lpp of gram‐negative bacteria either stay at the inner membrane or are exported to the outer membrane through the Lol (localization of lipoprotein) system (Narita, Matsuyama, & Tokuda, [2004](#mbo3525-bib-0038){ref-type="ref"}; Tokuda & Matsuyama, [2004](#mbo3525-bib-0069){ref-type="ref"}). However, Lpp that contain aspartate at position +2 (Asp+2) next to cysteine (+1) are hardly recognized by the Lol machinery. Therefore, these Lpp remain anchored at the inner membrane (Narita & Tokuda, [2011](#mbo3525-bib-0040){ref-type="ref"}; Okuda & Tokuda, [2011](#mbo3525-bib-0045){ref-type="ref"}). Thus in *E. coli*, the amino acid at position +2 determines the localization of Lpp either in inner or outer membrane (Yamaguchi, Yu, & Inouye, [1988](#mbo3525-bib-0070){ref-type="ref"}). By in silico prediction it was assumed that the residues following the +1 cysteine may contain the Lpp sorting information (Zuckert, [2014](#mbo3525-bib-0072){ref-type="ref"}).

Unlike gram‐negative bacteria, gram‐positive bacteria lack the outer membrane and the corresponding Lol machinery. Therefore, the influence of Asp+2 on Lpp sorting has not been explored. Since Lpp are the major surface proteins in gram‐positive bacteria, they play a crucial role in nutrient transport and in virulence (Nguyen & Götz, [2016](#mbo3525-bib-0042){ref-type="ref"}; Shahmirzadi, Nguyen, & Götz, [2016](#mbo3525-bib-0057){ref-type="ref"}). In gram‐positive pathogens Lpp play a crucial role in infection (Nguyen & Götz, [2016](#mbo3525-bib-0042){ref-type="ref"}; Takeuchi, Hoshino, & Akira, [2000](#mbo3525-bib-0065){ref-type="ref"}), sepsis (Angus & van der Poll, [2013](#mbo3525-bib-0001){ref-type="ref"}; Schmaler et al., [2009](#mbo3525-bib-0055){ref-type="ref"}), inflammation (Skabytska et al., [2014](#mbo3525-bib-0059){ref-type="ref"}), and immune modulation via TLR2‐MyD88 activation (Hashimoto et al., [2006](#mbo3525-bib-0018){ref-type="ref"}; Schmaler et al., [2009](#mbo3525-bib-0055){ref-type="ref"}; Takeuchi et al., [2000](#mbo3525-bib-0065){ref-type="ref"}).

While diacylated Lpp are sensed by the TLR2/TLR6 heterodimer, triacylated Lpp are sensed by the TLR2/TLR1 heterodimer (Jin et al., [2007](#mbo3525-bib-0026){ref-type="ref"}; Kang et al., [2009](#mbo3525-bib-0027){ref-type="ref"}; Schenk, Belisle, & Modlin, [2009](#mbo3525-bib-0053){ref-type="ref"}; Takeda, Takeuchi, & Akira, [2002](#mbo3525-bib-0064){ref-type="ref"}). As the Lpp receptors TLR2, TLR1, and TLR6 recognize Lpp via their ectodomain (Jimenez‐Dalmaroni et al., [2015](#mbo3525-bib-0025){ref-type="ref"}) it is assumed that soluble Lpp in the bacterial supernatant bind to their receptors. It means that certain Lpp are not permanently anchored in the outer leaflet of the cytoplasmic membrane but are released into the environment during growth. Indeed, it has been shown recently that *S. aureus* strains that produce the detergent‐like phenol‐soluble modulins (PSMs) (Cheung, Joo, Chatterjee, & Otto, [2014](#mbo3525-bib-0008){ref-type="ref"}) release higher amounts of Lpp from the cytoplasmic membrane (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}).

As the amount of released Lpp into the environment is correlated with the immune response we asked the question whether negatively charged amino acids (aa) next to the cysteine in position +1 strengthens the anchoring of Lpp at the membrane by ionic interaction with positive charged phospholipids. To strengthen the hypothesis that the negative charged Asp+2 interacts with a positive charged membrane phospholipid, we created a Δ*mpr*F mutant in USA300. MprF lysinylates phosphatidylglycerol to Lys‐PG, one of the dominant membrane phospholipids in *S. aureus* (Ernst et al., [2015](#mbo3525-bib-0012){ref-type="ref"}; Peschel et al., [2001](#mbo3525-bib-0047){ref-type="ref"}; Staubitz, Neumann, Schneider, Wiedemann, & Peschel, [2004](#mbo3525-bib-0061){ref-type="ref"}). In the *mprF* mutant the positive lysyl group is absent and now we saw that in this mutant Lpl8^+2D^ is not more retained to the membrane than Lpl8^+2S.^ This result clearly indicates that the strong retention of Lpl8^+2D^ to the membrane is most likely due to its ionic interaction with the positive charged Lys‐PG.

Furthermore, we screened all known Lpp of *S. aureus* USA300 for the +1 to +3 amino acid of the mature Lpp and found that Lpp with glycine at position +2 (G^+2^) were the most abundant in the supernatant, whereas Lpp with an Asp at position +2 (D^+2^) were hardly found in the supernatant (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}; Nguyen et al., [2016](#mbo3525-bib-0044){ref-type="ref"}; Stoll, Dengjel, Nerz, & Götz, [2005](#mbo3525-bib-0062){ref-type="ref"}).

2. MATERIALS AND METHODS {#mbo3525-sec-0002}
========================

2.1. Bacterial strains and growth conditions {#mbo3525-sec-0003}
--------------------------------------------

Bacterial strains and plasmids used in this study are listed in Table [1](#mbo3525-tbl-0001){ref-type="table-wrap"}. *S. aureus* strains were grown aerobically in basic medium, BM (1% soy peptone, 0.5% yeast extract, 0.5% NaCl, 0.1% glucose, and 0.1% K~2~HPO~4~, pH 7.4) at 37°C. For strains containing the plasmid pCtuf, the media were supplemented with 10 μg/ml of chloramphenicol.

###### 

Strains and plasmids used in this study

  Strains and plasmids                Description                                                                                              References
  ----------------------------------- -------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------
  Strains                                                                                                                                      
  * E. coli* DC10B                    A DNA cytosine methyltransferase mutant in the high‐efficiency *Escherichia coli* cloning strain DH10B   (Monk, Shah, Xu, Tan, & Foster, [2012](#mbo3525-bib-0036){ref-type="ref"})
  * S. aureus* RN4220                 A mutant of strain 8325‐4 that accepts the foreign DNA                                                   (Thomas & Archer, [1989](#mbo3525-bib-0067){ref-type="ref"})
  * *SA113∆*spa::erm*                 Deletion of *spa* gene with erythromycin marker                                                          (Schlag et al., [2010](#mbo3525-bib-0054){ref-type="ref"})
  * *USA300∆*lpl*                     Markerless deletion of lpl operon                                                                        (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}; Nguyen et al., [2016](#mbo3525-bib-0044){ref-type="ref"})
  * *USA300∆*lpl*∆*spa::erm*          Markerless deletion of lpl and deletion of spa gene                                                      This study
  * *USA300∆*lpl*∆*spa::erm*∆*mprF*   Clean deletion of *mpr*F gene in USA300∆*lpl*∆*spa*::*erm*                                               This study
  Plasmids                                                                                                                                     
  * *pBASE                            Shutte vector for markerless gene deletion                                                               (Bae & Schneewind, [2006](#mbo3525-bib-0002){ref-type="ref"})
  * *pBASE‐*mpr*F                     Knock‐out plasmid for replacement of *mpr*F                                                              This study
  * *pCtuf                            Constitutive expression vector for staphylococci                                                         (Biswas et al., [2006](#mbo3525-bib-0006){ref-type="ref"})
  * *pCtuf‐lpl8^+2D^strep             Constitutive expression of *lpl*8 wild type                                                              This study
  * *pCtuf‐lpl8^+2S^strep             Constitutive expression of *lpl*8 with serine at +2 position                                             This study
  * *pCtuf‐SitC^+2D^strep             Constitutive expression of *sitC* with aspartate in +2 position                                          This study
  * *pCtuf‐SitC^+2G^strep             Constitutive expression of *sitC* wild type                                                              This study
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2.2. Creation of a double mutant *S. aureus* USA300∆*lpl*∆*spa::erm* by phage transduction {#mbo3525-sec-0004}
------------------------------------------------------------------------------------------

In order to avoid unnecessary binding of IgG to protein A, the *spa* gene was deleted by phage transduction using Φ11 with SA113 *spa*::*erm* (Schlag et al., [2010](#mbo3525-bib-0054){ref-type="ref"}) as donor strain; as a result strain USA300∆*lpl*∆*spa::erm* was created. Briefly, phage Ф11 was used to produce a phage lysate of SA113∆*spa*::*erm*. The lysate was filtered through a 0.2 μm pore‐size filter and used to infect strain USA300∆*lpl* at a low multiplicity of infection (phage‐to‐recipient ratio of 1:10). Transducants carrying ∆*spa*::*erm* were selected on tryptic soya agar (TSA) supplied with erythromycin 2.5 μg/ml. As a control, the phage lysate was plated alone to avoid reisolating the donor strain. Positive clones containing the *spa* deletion were confirmed by DNA sequencing. For that, genomic DNA was isolated from clones using Quick‐gDNA^™^ Miniprep Kit (Zymo Research Europe GmbH) and used as template for PCR, using the primers For.spa.seq (5'‐AAGACCATGCTGAACAATTATTAGCTCA‐3') and Rev.spa.seq (5'‐TGCAGGTGGTGTAGCAGCGAAAC‐3'). The PCR products were purified using illustra GFX PCR DNA and Gel Band Purification Kits (GE healthcare) and send for sequencing (GATC Biotech AG) to confirm *spa* deletion. All primers were purchased from integrated DNA technologies (Idt, Illinois).

2.3. Deletion of *mpr*F gene by allelic replacement in *S. aureus* USA300∆*lpl*∆*spa*::*erm* {#mbo3525-sec-0005}
--------------------------------------------------------------------------------------------

The deletion of *mpr*F gene in *S. aureus* USA300∆*lpl*∆*spa*::*erm* was generated by homologous recombination. First, pBASE‐*mpr*F knockout plasmid containing the upstream and downstream flanking region was constructed. The 1000 bp upstream fraction was amplified by PCR using primer pairs F_up (5'‐GGAATT CCGGAGCTCGGTACTCTACTTGAAAAAATGAGTGTTC‐3') and R_up (5'‐TTAATTATTTGTGCTGATTCATTTTTTCACATCAATTC‐3') and the 741 bp downstream using F_down (5'‐AATGAATCAGCACAAATAATTAAAATCCAAGTGC‐3') and R_down (5'‐CGACAGATCTGCGCGCTAGCTACTAAGGTCTAATGAAAGGATG‐3'). These two fragments were ligated into linearized pBASE by Gibson Assembly method. Briefly, the mixture of purified PCR flanking fragments and linearized plasmid were mixed 2xHiFi DNA Assembly Master Mix (New England Biolabs Inc., UK) at ratio 1:1 and incubated at 50°C for 1 hr. Later the ligation mixture was transformed into chemo‐competent *E. coli* DC10B and plated onto BM Ampicillin (100 μg/ml) plate and incubated at 37°C. The clones containing plasmid pBASE‐*mpr*F were screened using colony PCR and confirmed by DNA sequencing. The correct plasmid pBASE‐*mpr*F subsequently transformed by electroporation into USA300∆*lpl*∆*spa*::*erm*. The deletion procedure of *mpr*F gene was followed as described previously (Bae & Schneewind, [2006](#mbo3525-bib-0002){ref-type="ref"}). The final gene deletion was checked and confirmed by PCR and DNA sequencing.

2.4. Construction of pCtuf‐Lpl8‐strep and pCtuf‐SitC‐strep {#mbo3525-sec-0006}
----------------------------------------------------------

To construct the plasmid pCtuf for expression of Lpl8, the *lpl*8^+2D^ sequence was amplified from *S. aureus* USA300 genomic DNA, using the primers: Forward primer F_lpl8^+2D^ (5'‐AATAT[TTAATTAA]{.ul}TGAAGTCTATAAAAAGGATTGGATTG‐3') and Reverse primer R_lpl8‐strep (5'‐ ATT[AAGCTT]{.ul}ATTATT**TTTCAAATTGTGGATGTGACCATT**TATCCTCGCTTGGATTAAAG ‐ 3') (restriction sites PacI and HindIII are underlined, respectively). The strep‐tag nucleotide sequence (bold letters) was added in the reverse primer for downstream protein detection. To develop the Lpl8 containing Serine at +2 position (Ser+2), the serine at the 24th codon was replaced into aspartate (D24S) using the forward primer F_lpl8^+2S^ (5'‐ataT[TTAATTAA]{.ul}TGAAGTCTATAAAAAGGATTGGATTGTGCATTAGTTTGTTGATTTTAATCATCTTTGTTACATCTTGT**TCT**GGTGATAATAAG‐3') with the substituted nucleotide sequence (bold letters) and restriction site PacI in underline. The *lpl*8^+2S^ sequence was amplified with a pair of primers F_lpl8^+2S^ and R_lpl8‐strep. The amplified fragments and plasmid pCtuf were cut using the same digestion enzymes (PacI and HindIII) and subsequently ligated together (T4 Rapid ligation Kit by Thermo Scientific). The ligation products were transformed into *S. aureus* RN4220 by electroporation to yield the plasmid pCtuf‐*lpl*8^+2D^ and pCtuf‐*lpl*8^+2S^, which were then transformed into *S. aureus* USA300Δ*lpl* **∆** *spa::erm* (Figure [1](#mbo3525-fig-0001){ref-type="fig"}a and b). For PCR amplification of *sitC* ^+2G^ sequence, forward primer F_SitC^+2G^ (5'‐AATA[TTAATTAA]{.ul}TGAAAAAATTAGTACCTTTATTATTAGCCT‐3') and reverse primer R_SitC‐strep (5'‐AATT[AAGCTT]{.ul}ATTATT**TTTCAAATTGTGGATGTGACCATT**TCATGCTTCCGTGTACAGTTTCAATATTT‐3') were used. Restriction sites PacI and HindIII are underlined, respectively, and in the reversed primer strep‐tag nucleotide sequence was added (bold letters). To create *Sit*C sequence with Asp+2, the glycine at the 19th codon was replaced by the aspartate codon (G19D) using the forward primer F_SitC^+2D^ (5'‐ATA[TTAATTAA]{.ul}TGAAAAAATTAGTACCTTTATTATTAGCCTTATTACTTCTAGTTGCTGCATGT**GAT**ACTG‐3') with the substituted nucleotide sequence (bold letters) and restriction site PacI underlined. The *sitC* ^+2D^ sequence was amplified with a pair of primers F_SitC^+2D^ and R_SitC‐strep. Two resulting plasmid pCtuf‐SitC^+2G^ and pCtuf‐SitC^+2D^ were cloned into *S. aureus* RN4220 and later in USA300Δ*lpl* **∆** *spa::erm* (Figure [1](#mbo3525-fig-0001){ref-type="fig"}c and d). The strain carrying the pCtuf plasmid without inserted fragment was used as negative control.

![Schematic representation of plasmid constructs used in the study for lipoprotein release in *S. aureus*. The initial plasmid pCtuf were inserted with either (a) lpl8^+2D^, (b) lpl8^+2S^, (c) SitC^+2G^, and (d) SitC^+2D^, all with c‐terminal strep‐tag sequence (See methods for detail). The expression of Lpl8 and SitC variant were under the constitutive control of elongation tufA promoter](MBO3-6-na-g001){#mbo3525-fig-0001}

2.5. Harvesting of extracellular proteins {#mbo3525-sec-0007}
-----------------------------------------

For the detection of extracellular proteins *S. aureus* clones were grown aerobically in BM with 10 μg/ml chloramphenicol at 37°C. Overnight cultures were diluted 1:100 in 100 ml BM broth and incubated aerobically at 37°C. Samples were taken at 4, 8, and 16 hr and OD~578 nm~ was determined at each time point. Samples were centrifuged at 5,000*g*/10 min at 4°C, filtered through 0.22 μm filters (Sarstedt, Nümbrecht). The amount of supernatant proteins was determined and adjusted to the same concentration. The filtered supernatants were kept at −80°C. The samples were thawed and prepared as described earlier (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}).

2.6. Western blot {#mbo3525-sec-0008}
-----------------

For Western blot analysis, the supernatants were thawed on ice and precipitated by 10 μl Strata clean resin (Agilent, Waldbronn). For SDS PAGE, the precipitated proteins were dissolved in 50 μl sample loading dye (3 X Laemmli beta‐mercaptoethanol), boiled for 7 min and stored on ice. 10 μl of each sample was loaded on 12% SDS‐PAGE. After gel electrophoresis proteins were transferred onto nitrocellulose membrane (Protran, GE, Frankfurt am Main) using Trans Blot device (Bio‐Rad, Munich) at 350 V for 40 min. Membranes were then blocked overnight with RotiBlock blocking reagent (Roth, Karlsruhe). Membranes were incubated with primary antibody (anti‐strep‐tag rabbit IgG, Abcam) for 1 hr and subsequently with secondary antibodies (anti‐rabbit IgG goat IgG alkaline phosphatase conjugated, Sigma) for 1 hr each at room temperature under gentle shaking. Detection was carried out using BCI/NBP (Sigma, Munich); blots were scanned by Epson scanner.

3. RESULTS {#mbo3525-sec-0009}
==========

3.1. The lipoproteins with Asp at position +2 are not frequent in gram‐positive bacteria {#mbo3525-sec-0010}
----------------------------------------------------------------------------------------

First, we investigated how frequent is Asp+2 is gram‐positive Lpp. We used PRED‐LIPO prediction program for analyzing Lpp of gram‐positive bacteria (<http://biophysics.biol.uoa.gr/PRED-LIPO-results/>) (Bagos, Tsirigos, Liakopoulos, & Hamodrakas, [2008](#mbo3525-bib-0004){ref-type="ref"}). The program includes Lpp data of 179 gram‐positive species and strains. There are three species representatives that lacked Lpp: The mycoplasma‐like plant pathogens *Aster yellows witches‐broom phytoplasma* AYWB and *Onion yellows phytoplasma* as well as the lactic acid bacterium *Oenococcus oeni* PSU‐1. The other of the 176 species/strains contain a wide variety of 9--160 Lpp. Only 62 out of 176 species/strains contain Lpp with Asp (+2). The number of Lpp with Asp+2 was very low ranging from 0% to 6% per species/strain (Table [S1).](#mbo3525-sup-0001){ref-type="supplementary-material"}

To illustrate the low distribution of Lpp with Asp+2 we show a selection of gram‐positive species representative (Figure [2](#mbo3525-fig-0002){ref-type="fig"}). As can be seen in the average the occurrence of Lpp with (Asp+2) ranged from 0% to 6%. Exceptionally high percentage (7 Lpp ≈ 10%) was the number of Lpp with (Asp+2) in the multiresistant and epidemic *S. aureus* USA300. Five of the seven Lpp with Asp+2 are encoded in the *lpl* gene cluster that is only found in the *S. aureus* species (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}; Nguyen et al., [2016](#mbo3525-bib-0044){ref-type="ref"}). The number of *lpl* genes in this cluster varies from 3 to 10 among the strains. Unlike in gram‐negative bacteria the number of Lpp with Asp+2 is limited in gram‐positive bacteria. Using *S. aureus* USA300 as a prototype of pathogenic *S. aureus* strains we found that among the 67 Lpp the most abundant amino acid at position +2 was glycine (39 Lpp), followed by serine (12 Lpp), aspartate (7 Lpp), alanine (3 Lpp), and each one with arginine, threonine, glutamine, asparagine, glutamate, and valine (Table [2](#mbo3525-tbl-0002){ref-type="table-wrap"}).

![The dissemination of Lpp with aa at position +2 in gram‐positive species/strains. The percentages of Lpp with four groups of aa (Asp, Gly, Ser, and others) per total number of Lpp of several gram‐positive strains were shown. The calculation based on the PRED‐LIPO data. The detail data of Lpp with Asp+2 in 179 species/strains are presented in Table [S1](#mbo3525-sup-0001){ref-type="supplementary-material"}. S., Staphylococcus; Strep., Streptococcus; B., Bacillus; C., Clostridium; M., Mycobacterium; Cor., Corynebacterium; L., Listeria; Myc., Mycoplasma](MBO3-6-na-g002){#mbo3525-fig-0002}

###### 

List of amino acids (aa) at the position +2 in *S. aureus* USA300 Lpp

  aa at position +2[a](#mbo3525-note-0002){ref-type="fn"}   Frequency   Number of detected Lpp in exoproteome[b](#mbo3525-note-0003){ref-type="fn"}   References
  --------------------------------------------------------- ----------- ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  G                                                         39          29                                                                            (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Burlak et al., [2007](#mbo3525-bib-0007){ref-type="ref"}; Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Enany, Yoshida, & Yamamoto, [2014](#mbo3525-bib-0011){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel, Herbst, Moche, Hecker, & Becher, [2011](#mbo3525-bib-0020){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"}; Pocsfalvi et al., [2008](#mbo3525-bib-0048){ref-type="ref"}; Ravipaty & Reilly, [2010](#mbo3525-bib-0050){ref-type="ref"}; Sibbald et al., [2006](#mbo3525-bib-0058){ref-type="ref"}; Ziebandt et al., [2010](#mbo3525-bib-0071){ref-type="ref"})
  S                                                         12          9                                                                             
  D                                                         **7**       **0**                                                                         
  A                                                         3           3                                                                             
  R                                                         1           1                                                                             
  T                                                         1           1                                                                             
  Q                                                         1           0                                                                             
  N                                                         1           0                                                                             
  E                                                         1           0                                                                             
  V                                                         1           0                                                                             
  Total                                                     67          43                                                                            

aa, amino acids; G, glycine; S, serine; D, aspartate; A, alanine; R, arginine; T, threonine; Q, glutamine; N, asparagine; E, glutamate; V, valine.

The frequency of amino acid at +2 position out of 67 predicted and approved Lpp of *S. aureus* USA300.

The number of Lpp detected in the exoproteome of various *S. aureus* strains.
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3.2. Evaluation of *S. aureus* Lpp detected in exoproteome {#mbo3525-sec-0011}
----------------------------------------------------------

Next we analyzed the published exoproteomic data of *S. aureus* to see which Lpp with amino acid in position +2 are preferentially found in the supernatant. It turned out that in the supernatant particularly Lpp with uncharged or positively charged aa in position 2 were found: such as glycine, serine, alanine, arginine, and threonine. Lpp with aspartate in position 2 (Asp+2) were not detected in the exoproteome of various *S. aureus* strains. The results are summarized in Table [2](#mbo3525-tbl-0002){ref-type="table-wrap"}, and the full detailed list of Lpp is shown in Table [3](#mbo3525-tbl-0003){ref-type="table-wrap"}.

###### 

Lpp detected in culture supernatant of *Staphylococcus aureus* strains either directly or via immunoproteomics

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No     Locus tag in USA300   Function/ Annotation                                                 aa sequence after Cysteine   Transmembrane domain (TMD)   Working strains                 Exoproteome    References
  ------ --------------------- -------------------------------------------------------------------- ---------------------------- ---------------------------- ------------------------------- -------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\.    SAUSA300_1978         Ferric‐hydroxamate receptor/ FhuD1                                   **C** SASV                   No TMD                       D30\                            Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300                                         

  2\.    SAUSA300_2235         Iron compound ABC transporter, iron compound‐binding protein FhuD2   **C** GNQG                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              O46\                                           
                                                                                                                                                              O11\                                           
                                                                                                                                                              USA300\                                        
                                                                                                                                                              D30\                                           
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              Multiple *S. aureus* strains                   

  3\.    SAUSA300_0721         Transferrin receptor/ SstD                                           **C**GNNS                    No TMD                       COL\                            Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              D30\                                           
                                                                                                                                                              USA300\                                        
                                                                                                                                                              Multiple *S. aureus* strains                   

  4\.    SAUSA300_0117         Fe ABC transporter / SirA                                            **C** SGNS                   No TMD                       COL\                            Detected       (Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"})
                                                                                                                                                              O46\                                           
                                                                                                                                                              O11\                                           
                                                                                                                                                              USA300                                         

  5\.    SAUSA300_1032         Fe ABC transporter/ IsdE                                             **C** QSSS                   No TMD                       --------                        Not‐detected   --------

  6\.    SAUSA300_0344         FepA, Fe‐binding protein, part of fepABC and tat‐AC cluster          **C** GNDD                   No TMD                       --------                        Not‐detected   --------

  7\.    SAUSA300_2136         Fe ABC transporter                                                   **C** GNTD                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Herbert et al., [2010](#mbo3525-bib-0021){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"})
                                                                                                                                                              MRSA clinical isolates\                        
                                                                                                                                                              USA300\                                        
                                                                                                                                                              O46\                                           
                                                                                                                                                              O11\                                           
                                                                                                                                                              Multiple *S. aureus* strains                   

  8\.    SAUSA300_0219 nq      Iron Binding Protein                                                 **C** ANTR                   No TMD                       D30\                            Detected       (Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              strain 930918‐3                                

  9\.    SAUSA300_0618         Manganese‐binding protein MntC (SitC)                                **C** GTGG                   No TMD                       O46\                            Detected       (Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              O11\                                           
                                                                                                                                                              D30\                                           
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300                                         

  10\.   SAUSA300_2351         Zinc‐binding, adcA‐like                                              **C** GNDD                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  11\.   SAUSA300_2411         Cobalt and nickel transporter Cnt (Opp1A)                            **C** GGNK                   No TMD                       COL\                            Detected       (Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"})
                                                                                                                                                              O46\                                           
                                                                                                                                                              O11\                                           
                                                                                                                                                              USA300                                         

  12\.   SAUSA300_0231         Nickel ABC transporter                                               **C** GSMH                   No TMD                       D30\                            Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300                                         

  13\.   SAUSA300_0203         Nickel‐Peptide/ transporter substrate‐binding protein                **C** GVPT                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  14\.   SAUSA300_2230         Molybdenum ABC transporter (ModA)                                    **C** SNSN                   No TMD                       D30\                            Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300                                         

  15\.   SAUSA300_1283         Thioredoxine reductase,\                                             **C** GGGN                   No TMD                       Various *S. aureus* strains     Detected       (Sibbald et al., [2006](#mbo3525-bib-0058){ref-type="ref"})
                               phosphate ABC transporter, phosphate‐binding protein PstS                                                                                                                     

  16\.   SAUSA300_0145         Phosphonate ABC transporter                                          **C** GNSS                   No TMD                       D30\                            Detected       (Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              strain 930918‐3                                

  17\.   SAUSA300_0175         Nitrate ABC transporter substrate‐binding protein                    **C D**WQR                   No TMD                       ------                          Not‐detected   ------

  18\.   SAUSA300_2391         Glycine betaine /carnitine/ choline ABC transporter (OpuCc)          **C** SLPG                   No TMD                       D30\                            Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              strain 930918‐3                                

  19\.   SAUSA300_2359         Amino acid ABC transporter                                           **C** GNNS                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"}; Ravipaty & Reilly, [2010](#mbo3525-bib-0050){ref-type="ref"})
                                                                                                                                                              SA strain D30\                                 
                                                                                                                                                              SA\                                            
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300\                                        
                                                                                                                                                              Multiple *S. aureus* strains                   

  20\.   SAUSA300_0073         Peptide ABC transporter                                              **C** GNGQ                   No TMD                       ------                          Not‐detected   ------

  21\.   SAUSA300_0891         Oligopeptide ABC transporter (Opp3A)                                 **C** ANDD                   No TMD                       COL\                            Detected       (Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              D30\                                           
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300\                                        
                                                                                                                                                              Multiple *S. aureus* strains                   

  22\.   SAUSA300_0892         Oligopeptide ABC transporter (Opp4A)                                 **C** GKSS                   No TMD                       USA300                          Not‐detected   ------

  23\.   SAUSA300_0437         NLPA/ D‐Methionine binding (GmpC)                                    **C** GGNN                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})
                                                                                                                                                              USA300                                         

  24\.   SAUSA300_0798         D‐Methionine ABC transporter                                         **C** GNGN                   No TMD                       MSSA\                           Detected       (Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Enany et al., [2014](#mbo3525-bib-0011){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})
                                                                                                                                                              MRSA\                                          
                                                                                                                                                              USA300                                         

  25\.   SAUSA300_0209         Maltose ABC transporter                                              **C** GPNR                   No TMD                       ------                          Not‐detected   --------

  26\.   SAUSA300_1884         CamS sex pheromone biosynthesis                                      **C** GNHK                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})
                                                                                                                                                              USA300                                         

  27\.   SAUSA300_0963         Quinol oxidase, subunit II (QoxA)                                    **C** SNIE                   2 TMD                        USA300\                         Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"})
                                                                                                                                                              Multiple *S. aureus* strains                   

  28\.   SAUSA300_0693         Electron transfer domain/ SaeP                                       **C** GNSN                   No TMD                       Multiple strains\               Detected       (Pocsfalvi et al., [2008](#mbo3525-bib-0048){ref-type="ref"}; Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Herbert, Ziebandt et al., [2010](#mbo3525-bib-0071){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"}; Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})
                                                                                                                                                              COL\                                           
                                                                                                                                                              MRSA clinical isolates\                        
                                                                                                                                                              O46\                                           
                                                                                                                                                              O11\                                           
                                                                                                                                                              USA300\                                        
                                                                                                                                                              Multiple *S. aureus* strains                   

  29\.   SAUSA300_1790         Foldase protein PrsA                                                 **C** GASA                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Diep et al., [2014](#mbo3525-bib-0010){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"}; Ravipaty & Reilly, [2010](#mbo3525-bib-0050){ref-type="ref"})
                                                                                                                                                              O46\                                           
                                                                                                                                                              O11\                                           
                                                                                                                                                              USA300                                         

  30\.   SAUSA300_2354         Thioredoxin/ Protein disulfide‐isomerase                             **C** GKKE                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  31\.   SAUSA300_2046         YidC (OxaA) ‐ essential protein                                      **C D**YSK                   5 TMD                        --------                        Not‐detected   --------

  32\.   SAUSA300_1436         PhiSLT ORF144‐like                                                   **C** GEKE                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  33\.   pUSA300_HOUMR0011     Membrane bound penicillinase BlaZ                                    **C** NSNS                   No TMD                       --------                        Not‐detected   --------

  34\.   SAUSA300_0410         Lpl‐1 νSaα specific                                                  **C** GKGN                   No TMD                       --------                        Not‐detected   ------

  35\.   SAUSA300_0411         Lpl‐2 νSaα specific                                                  **C D**SSS                   No TMD                       --------                        Not‐detected   ------

  36\.   SAUSA300_0413         Lpl‐3 νSaα specific                                                  **C D**KSS                   No TMD                       --------                        Not‐detected   ------

  37\.   SAUSA300_0414         Lpl‐4 νSaα specific                                                  **C D**GDN                   No TMD                       --------                        Not‐detected   ------

  38\.   SAUSA300_0415         Lpl‐5 νSaα specific                                                  **C D**SQS                   No TMD                       --------                        Not‐detected   --------

  39\.   SAUSA300_0416         Lpl‐6 νSaα specific                                                  **C E**SNK                   No TMD                       --------                        Not‐detected   --------

  40\.   SAUSA300_0417         Lpl‐7 νSaα specific                                                  **C** RNMK                   No TMD                       --------                        Not‐detected   --------

  41\.   SAUSA300_0418         Lpl‐8 νSaα specific                                                  **C D**GDN                   No TMD                       --------                        Not‐detected   --------

  42\.   SAUSA300_0419         Lpl‐9 νSaα specific                                                  **C** GNMK                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"}; Ravipaty & Reilly, [2010](#mbo3525-bib-0050){ref-type="ref"})
                                                                                                                                                              D30\                                           
                                                                                                                                                              USA300\                                        
                                                                                                                                                              Multiple *S. aureus* strains                   

  43\.   SAUSA300_2429         Tandem lpp                                                           **C** VIMT                   No TMD                       ------                          Not‐detected   --------

  44\.   SAUSA300_2430         Tandem lpp                                                           **C** GMKK                   No TMD                       ------                          Not‐detected   --------

  45\.   SAUSA300_0100         Tandem lpp/ Conserved staphylococcal\                                **C** GIGK                   No TMD                       Various *S. aureus* strains\    Detected       (Sibbald et al., [2006](#mbo3525-bib-0058){ref-type="ref"}; Herbert, Ziebandt et al., [2010](#mbo3525-bib-0071){ref-type="ref"})
                               antigen 1A (Csa1A)                                                                                                             MRSA clinical isolates                         

  46\.   SAUSA300_0101         Tandem lpp                                                           **C** GMGK                   No TMD                       --------                        Not‐detected   --------

  47\.   SAUSA300_0102         Tandem lpp                                                           **C** GIGK                   No TMD                       --------                        Not‐detected   --------

  48\.   SAUSA300_0103         Tandem lpp                                                           **C** GIGK                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  49\.   SAUSA300_0079         Unknown function                                                     **C** SNND                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  50\.   SAUSA300_0372         Unknown function                                                     **C** GNDT                   No TMD                       D30\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Burlak et al., [2007](#mbo3525-bib-0007){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Hempel et al., [2011](#mbo3525-bib-0020){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"}; Pocsfalvi et al., [2008](#mbo3525-bib-0048){ref-type="ref"}; Ravipaty & Reilly, [2010](#mbo3525-bib-0050){ref-type="ref"}; Sibbald et al., [2006](#mbo3525-bib-0058){ref-type="ref"})
                                                                                                                                                              Multiple strains\                              
                                                                                                                                                              USA300\                                        
                                                                                                                                                              COL\                                           
                                                                                                                                                              *S. aureus* COL\                               
                                                                                                                                                              MW2 and LAC                                    

  51\.   SAUSA300_0377         Unknown function                                                     **C** ASDQ                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  52\.   SAUSA300_1492         Unknown function                                                     **C** GSQN                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  53\.   SAUSA300_0992         Cell‐wall binding lipoprotein                                        **C** TTDK                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Muthukrishnan et al., [2011](#mbo3525-bib-0037){ref-type="ref"})
                                                                                                                                                              D30\                                           
                                                                                                                                                              strain 930918‐3\                               
                                                                                                                                                              USA300                                         

  54\.   SAUSA300_2403         Unknown function                                                     **C** GKEQ                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  55\.   SAUSA300_0724         Unknown function                                                     **C** GNKE                   No TMD                       MRSA clinical isolates          Detected       (Sibbald et al., [2006](#mbo3525-bib-0058){ref-type="ref"}; Herbert, Ziebandt et al., [2010](#mbo3525-bib-0071){ref-type="ref"})

  56\.   SAUSA300_2315         Unknown function                                                     **C** GQDS                   No TMD                       Multiple *S. aureus* strains\   Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"}; Kusch & Engelmann, [2014](#mbo3525-bib-0030){ref-type="ref"})
                                                                                                                                                              USA300                                         

  57\.   SAUSA300_2614         Unknown function                                                     **C** SKQN                   No TMD                       --------                        Not‐detected   --------

  58\.   SAUSA300_0663         Unknown function                                                     **C** GKSQ                   No TMD                       --------                        Not‐detected   --------

  59\.   SAUSA300_1106         Unknown function                                                     **C** SFGG                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Herbert, Ziebandt et al., [2010](#mbo3525-bib-0071){ref-type="ref"})
                                                                                                                                                              MRSA clinical isolates\                        
                                                                                                                                                              USA300\                                        
                                                                                                                                                              Multiple *S. aureus* strains                   

  60\.   SAUSA300_0303         Unknown function                                                     **C** SNKG                   No TMD                       --------                        Not‐detected   --------

  61\.   SAUSA300_1478         Unknown function                                                     **C** GQKY                   No TMD                       USA300                          Detected       (Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})

  62\.   SAUSA300_1376         Unknown function                                                     **C** STTN                   No TMD                       MRSA clinical isolates          Detected       (Herbert, Ziebandt et al., [2010](#mbo3525-bib-0071){ref-type="ref"})

  63\.   SAUSA300_1379         Unknown function                                                     **C** STTN                   No TMD                       --------                        Not‐detected   ----------

  64\.   SAUSA300_1440         Unknown function                                                     **C** STME                   No TMD                       Various *S. aureus* strains     Detected       (Sibbald et al., [2006](#mbo3525-bib-0058){ref-type="ref"})

  65\.   SAUSA300_1742         Unknown function                                                     **C** GANQ                   No TMD                       O46\                            Detected       (Le Marechal et al., [2011](#mbo3525-bib-0031){ref-type="ref"})
                                                                                                                                                              O11                                            

  66\.   SAUSA300_1741         Unknown function                                                     **C** GANQ                   No TMD                       ------------                    Not‐detected   ------------

  67\.   SAUSA300_0769         Unknown function                                                     **C** GHHQ                   No TMD                       COL\                            Detected       (Becher et al., [2009](#mbo3525-bib-0005){ref-type="ref"}; Hanzelmann et al., [2016](#mbo3525-bib-0016){ref-type="ref"})
                                                                                                                                                              USA300                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

John Wiley & Sons, Ltd

3.3. The positive charged lysyl‐phosphatidylglycerol (Lys‐PG) enhances Lpl8 retention {#mbo3525-sec-0012}
-------------------------------------------------------------------------------------

In *S. aureus,* most of the Lpp containing Asp+2 belong to the Lpl lipoproteins. Previously it has been demonstrated that the Lpl lipoproteins are expressed both at transcriptional level and that they are associated with the cell envelope; their biological function is that they contribute to host cell invasion (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}; Nguyen et al., [2016](#mbo3525-bib-0044){ref-type="ref"}). To evaluate the effect of Asp+2 on Lpl release we substituted in Lpl8 (model Lpp) Asp+2 by Ser+2. Both genes encoding either Lpl8^+2D^ or the mutated Lpl8^+2S^ were provided with a Strep‐tag and were constitutively expressed on pCtuf vector in *S. aureus* USA300∆*lpl*∆*spa::erm* (Figure [1](#mbo3525-fig-0001){ref-type="fig"}a and b). The release of Lpl8^+2D^ and Lpl8^+2S^ into the supernatant was monitored over time by Western blotting using Strep‐tag specific antibodies. For equal protein concentrations, the samples were adjusted to the same A280/260 values (Figure [3](#mbo3525-fig-0003){ref-type="fig"}a). In the supernatants of the 4 hr cultures only faint bands were observed for Lpl8^+2D^ and Lpl8^+2S^. However, after 8 and 12 hr Lpl8^+2S^ was much more released than Lpl8^+2D^ (Figure [3](#mbo3525-fig-0003){ref-type="fig"}b). The release of Lpl8^+2S^ occurred mainly in the late exponential and stationary growth phase.

![SDS‐PAGE profile of supernatant proteins from USA300 ∆*lpl*∆*spa*::*erm*. The extracellular proteins were harvested from the culture supernatant of USA300 ∆*lpl*∆*spa*::*erm* (left) and USA300 ∆*lpl*∆*spa*::*erm*∆*mpr*F (right) with pCtuf‐empty as control (C), pCtuf‐lpl8^+2D^strep (lpl8^+2D^) and pCtuf‐lpl8^+2S^strep (lpl8^+2S^) at three different time points and concentrated with Strata clean resin (Agilent, Waldbronn). Supernatant proteins were separated on SDS‐page: (A) Gels were stained with Coomassie blue stain and (B) The Western blot of anti‐streptag AB](MBO3-6-na-g003){#mbo3525-fig-0003}

We assume that the negatively charged Asp (+2) of Lpp interacts with the positive charged lysyl‐phosphatidylglycerol (Lys‐PG) that is synthesized by MprF in *S. aureus*. To prove this hypothesis, we created a Δ*mpr*F mutant in USA300∆*lpl*∆*spa::erm* and compared the release of Lpl8^+2D^ and Lpl8^+2S^ in USA300∆*lpl*∆*mpr*F∆*spa*. As expected, in the *mprF* mutant there is no difference in release of Lpl8^+2S^ the Lpl8^+2D^ to the supernatant at any time points tested (Figure [3](#mbo3525-fig-0003){ref-type="fig"}b), indicating, that the positive charged Lysl‐PG increased the binding of Lpl8^+2D^ to the membrane.

3.4. The Asp (+2) has no effect on SitC release {#mbo3525-sec-0013}
-----------------------------------------------

Next, we selected another Lpp candidate, SitC (MntC), one of the most abundant Lpp in *S. aureus* which is involved in manganese (Mn) transport (Horsburgh et al., [2002](#mbo3525-bib-0022){ref-type="ref"}; Stoll et al., [2005](#mbo3525-bib-0062){ref-type="ref"}). Two versions of SitC supplied with C‐terminal strep‐tag were constitutively expressed on pCtuf vector in *S. aureus* USA300∆*lpl*∆*spa::erm*: the original SitC with glycine at position +2 (SitC^+2G^) and the mutated SitC with aspartate at position +2 (SitC^+2D^) (Figure [1](#mbo3525-fig-0001){ref-type="fig"}c and d). The release of SitC^+2G^ and SitC^+2D^ into the supernatant was monitored by Western blot in the same way as described for the Lpl8 variants. The protein samples were adjusted to the same A280/260 values to obtain an equal amount of extracellular proteins (Figure [4](#mbo3525-fig-0004){ref-type="fig"}a). In 4‐hr culture supernatant, neither SitC^+2G^ nor SitC^+2D^ were detected in the Western blot, but after 8‐hr and 12‐hr cultivation SitC was clearly detected (Figure [4](#mbo3525-fig-0004){ref-type="fig"}b). However, there was no difference observed in the release of both SitC variants.

![SDS‐PAGE profile of supernatant proteins from USA300 ∆*lpl*∆*spa*::*erm*. The extracellular proteins were harvested from the culture supernatant of USA300 ∆*lpl*∆*spa*::*erm* with pCtuf‐empty as control (C), pCtuf‐sitC^+2G^strep (sitC^+2G^) and pCtuf‐sitC^+2D^strep (sitC^+2D^) at three different time points (4, 8, and 16 hr) and concentrated with Strata clean resin (Agilent, Waldbronn). Supernatant proteins were separated on SDS‐page: (a) Gels were stained with Coomassie blue stain and (b) The Western blot of anti‐streptag AB](MBO3-6-na-g004){#mbo3525-fig-0004}

4. DISCUSSION {#mbo3525-sec-0014}
=============

Lipoproteins (Lpp) in gram‐positive bacteria have two major functions. They play an important role in physiology by being involved in transport of diverse nutrients, by acting as chaperons, by being involved in respiration, or by contributing to host cell invasion (Nguyen & Götz, [2016](#mbo3525-bib-0042){ref-type="ref"}; Shahmirzadi et al., [2016](#mbo3525-bib-0057){ref-type="ref"}). These functions are exerted by the protein part of the individual Lpp. Their second function is related to their interaction with the host\'s immune system. Here, it is not so much the protein part, but the lipid moiety plays the crucial role as potent activators of the innate and adaptive immune response by interacting with TLR2/1 or TLR2/6 receptors (Schenk et al., [2009](#mbo3525-bib-0053){ref-type="ref"}; Takeda et al., [2002](#mbo3525-bib-0064){ref-type="ref"}). Some Lpp were also considered as vaccine candidates. For example, immunization with FhuD2, a Lpp involved in ferric‐hydroxamate uptake, alone or together with hydroxamate siderophores, were protective in a murine staphylococcal infection model (Mishra et al., [2012](#mbo3525-bib-0035){ref-type="ref"}). Recently, the combination of five antigens provided close to 100% protection against four different *S. aureus* strains (Bagnoli et al., [2015](#mbo3525-bib-0003){ref-type="ref"}). Among them, were two Lpp, FhuD2 and the conserved staphylococcal antigen 1A (Csa1A).

Lpp in gram‐positive bacteria anchored in the outer leaflet of the cytoplasmic membrane. However, for the interaction with TLR2 receptor they must be released from the membrane to be able to expose the lipid moiety to the ectodomain of the TLR2‐(TLR1/6) heterodimers (Jimenez‐Dalmaroni et al., [2015](#mbo3525-bib-0025){ref-type="ref"}; Jin et al., [2007](#mbo3525-bib-0026){ref-type="ref"}). The less Lpp are released from the membrane the lower is the immune stimulation. We therefore asked the question how aa next to the invariable cysteine in position +1 contributes to the holding of Lpp to the membrane.

Here, we investigated the effect of aa at position +2 of the *S. aureus* Lpp in their release into the environment. In *E. coli* the significance of the aa at position +2 in withholding Lpp to the cytoplasmic membrane was well documented (Narita & Tokuda, [2016](#mbo3525-bib-0041){ref-type="ref"}; Okuda & Tokuda, [2011](#mbo3525-bib-0045){ref-type="ref"}). In several studies it has been reported that Asp+2 facilitates anchoring of Lpp at the inner membrane because Asp+2 functions as a Lol avoidance signal (Poquet, Kornacker, & Pugsley, [1993](#mbo3525-bib-0049){ref-type="ref"}; Seydel, Gounon, & Pugsley, [1999](#mbo3525-bib-0056){ref-type="ref"}; Terada, Kuroda, Matsuyama, & Tokuda, [2001](#mbo3525-bib-0066){ref-type="ref"}; Yamaguchi et al., [1988](#mbo3525-bib-0070){ref-type="ref"}). On the other hand, the outer membrane‐specific Lpp stimulated ATP hydrolysis by LolCDE but not the inner membrane‐specific Lpp (Masuda, Matsuyama, & Tokuda, [2002](#mbo3525-bib-0034){ref-type="ref"}). The Lol avoidance mechanism was based on the strength of the hydrogen bonds between the negative charged Asp+2 and the positive charged phosphatidyl ethanolamine (PE) of the membrane phospholipids; glutamate at +2 position, with its longer side chain, interacts differently with PE (Hara, Matsuyama, & Tokuda, [2003](#mbo3525-bib-0017){ref-type="ref"}). Therefore, the formation of a tight Lpp‐PE complex causes the Lol avoidance signal.

Like in *E. coli* there is in *S. aureus* also a predominant positive charged phospholipid, the Lys‐PG (Gould & Lennarz, [1970](#mbo3525-bib-0014){ref-type="ref"}), which is synthesized by MprF (Ernst et al., [2015](#mbo3525-bib-0012){ref-type="ref"}; Kuhn, Slavetinsky, & Peschel, [2015](#mbo3525-bib-0029){ref-type="ref"}; Peschel et al., [2001](#mbo3525-bib-0047){ref-type="ref"}). Lys‐PG, which yields 20%--40% of staphylococcus total membrane phospholipids, causes resistance against cationic antimicrobial compounds through ionic repulsion (Slavetinsky, Kuhn, & Peschel, [2016](#mbo3525-bib-0060){ref-type="ref"}). Given that, gram‐positive bacteria lack the Lol system it is still possible that Asp+2 strengthens the anchoring of the corresponding Lpp to the membrane via the interaction with the positively charged Lys‐PG. Indeed, that is the case as in a *mprF* mutant there was no difference in retention between Asp+2 or Ser+2 in our model Lpl8.

Screening of Lpp of gram‐positive bacteria for Asp+2 revealed that this aa is very rare at this position, and, if at all, it is mainly found in pathogenic species/strains of *Bacillus*,*Clostridium*,*Mycobacterium*,*Staphylococcus aureus*, and some streptococci (Table [S1](#mbo3525-sup-0001){ref-type="supplementary-material"}). To verify the question, we screened 13 publications containing exoproteomic data of *S. aureus* and found out that none of seven Lpp with Asp+2 were detected in supernatant (Table [2](#mbo3525-tbl-0002){ref-type="table-wrap"} and [3](#mbo3525-tbl-0003){ref-type="table-wrap"}). These seven Lpp with Asp+2 consist of; SAUSA300_0175 with a putative function as nitrate ABC transporter substrate‐binding protein, YidC (OxaI), and 5 Lpl lipoproteins. YidC, is an essential Lpp in bacteria acting as a membrane protein translocase and chaperone for membrane protein folding (Kuhn & Kiefer, [2017](#mbo3525-bib-0028){ref-type="ref"}). Lpl lipoproteins contribute to *S. aureus* invasion to the host cells and G2/M transition delay (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}; Nguyen et al., [2016](#mbo3525-bib-0044){ref-type="ref"}). We assume that for the function of these seven Lpp with Asp+2, a tighter anchoring to the cytoplasmic membrane is necessary for their function. Particularly the epidemic *S. aureus* strains, such as USA300, which contain seven Lpp with Asp+2. Five of these Lpp are encoded in the *lpl* operon of the νSAα genomic island (Diep et al., [2006](#mbo3525-bib-0009){ref-type="ref"}). This *lpl* operon contributes to host cell invasion via the protruding protein part (Nguyen et al., [2015](#mbo3525-bib-0043){ref-type="ref"}; Nguyen et al., [2016](#mbo3525-bib-0044){ref-type="ref"}). It makes sense that these Lpl proteins are especially tightly anchored to the cytoplasmic membrane to facilitate host cell invasion by interacting with the proposed target molecule at the host cell surface.

To experimentally verify the role of Asp+2 in retaining of Lpp at the cytoplasmic membrane we substituted the Lpl8^+2D^ by Lpl8^+2S^. We have chosen Ser as many Lpp with Gly or Ser in position +2 are found in the exoproteome (Table [2](#mbo3525-tbl-0002){ref-type="table-wrap"}). However, when we substituted SitC^+2G^ by SitC^+2D^; there was no difference in release into the supernatant (Figure [4](#mbo3525-fig-0004){ref-type="fig"}b). Apparently, aa in positions downstream of +2 might play a role. In Lpl8 for instance there is in position +4 a second aspartate **C**‐**D**G**D**N, whereas in SitC (MntC) **C**‐GTGG there is no Asp (Table [3](#mbo3525-tbl-0003){ref-type="table-wrap"}). These results suggest that aspartate in position +2 plays a role but is not sufficient to withhold Lpp tightly at the cytoplasmic membrane and aa in position +3 and +4 might also contribute to this function.

In *E. coli* it has been shown that besides the +2, aa at position +3 also contributes in sorting of Lpp to the inner or outer membrane. Glu, Asp, Gln, or Asn at +3 position enhanced the retention to the inner membrane, whereas His, Lys, Val, Ile, Ala, Cys, or Thr decreased it (Terada et al., [2001](#mbo3525-bib-0066){ref-type="ref"}). In *Pseudomonas aeruginosa* it was shown that Lys and Ser at positions +3 and +4 play a critical role for retaining Lpp in the inner membrane (Narita & Tokuda, [2007](#mbo3525-bib-0039){ref-type="ref"}) (Lewenza, Mhlanga, & Pugsley, [2008](#mbo3525-bib-0033){ref-type="ref"}). In *P. aeruginosa* Lpp that are located in the inner membrane have Gly+2 followed by Asp/Glu +3 (Remans, Vercammen, Bodilis, & Cornelis, [2010](#mbo3525-bib-0051){ref-type="ref"}). Recently, it has been shown that aa variations in +2 of the alkaline phosphatase (PhoA) expressed in *Mycoplasma gallisepticum* did not affect the retention of PhoA to the membrane (Panicker, Kanci, Markham, & Browning, [2016](#mbo3525-bib-0046){ref-type="ref"}). Finally, in *Bacillus subtilis* it was found that Gly+2 facilitates release of Lpp while a Ser+2 favors withholding in the membrane (Tjalsma & van Dijl, [2005](#mbo3525-bib-0068){ref-type="ref"}).

5. CONCLUSION {#mbo3525-sec-0015}
=============

An evaluation of literature data shows that in *S. aureus* the majority (75%) of Lpp found in the exoproteome carry Gly or Ser at position +2, whereas no Lpp with Asp in position +2 was found in the exoproteome. The role of Asp+2 in withholding Lpp to the cytoplasmic membrane was also confirmed by Lpl8^+2D^ and Lpl8^+2S^ in wild type but not in the *mprF* mutant. This suggests that the negative charged Asp withholds Lpp at the membrane by interacting with the positive charged Lys‐PG (Figure [5](#mbo3525-fig-0005){ref-type="fig"}). On the other hand, substitution of SitC^+2G^ by SitC^+2D^ did not lead to a decreased release into the supernatant, suggesting that in staphylococci positions +3 to +5 might also be important for a more tightly anchoring of Lpp in the membrane. In gram‐positive bacteria the release of Lpp into the supernatant is crucial for the immune modulation via TLR2 activation thus contributing to inflammation and infection. On the other hand, tightly anchored Lpp such as Lpls' or YidC is prerequisite for their function in host cell invasion and membrane protein sorting. Therefore, finding out sequence motives that modulate the strength of membrane anchoring is important.

![Model for the enforced interaction of Lpp Asp+2 (negative charged) with the Lys‐PG (positive charged). Phosphoglycerol (PG) in blue, Lys‐PG in red, D is Aspartate, C is Cysteine](MBO3-6-na-g005){#mbo3525-fig-0005}
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